Agent Factory in Pharma: Driving Autonomous Decisions in Drug Development and Pharmacovigilance

Overview Every week, safety scientists at pharmaceutical organizations process hundreds of Individual Case Safety Reports (ICSRs) under 15-day regulatory deadlines. Each report may arrive in a different language, reference local trade names, follow a different format, and be subject to a different regulatory jurisdiction. Despite this complexity, the core decision is always the same: does this case contain a safety signal worth escalating? The agent factory in pharma is changing how this complexity is handled.